BRSK2

BR serine/threonine kinase 2

Gene Information Card

Symbol BRSK2
Full Name BR serine/threonine kinase 2
Gene Type protein-coding
Chromosomal Location 11p15.5
NCBI Gene ID 9024 ncbi.nlm.nih.gov/gene/9024
Ensembl ID ENSG00000174697
UniProt ID Q8IWQ3
OMIM ID 609211
HGNC ID 18991
Aliases SAD1, SAD-B, STK29, BRSK2

Description

BRSK2 (BR serine/threonine kinase 2) encodes a member of the AMPK-related family of serine/threonine kinases. The protein is highly expressed in the brain and plays a critical role in neuronal polarization, axon formation, and synaptic function. It is activated by phosphorylation via LKB1 and regulates microtubule dynamics and cell cycle progression. BRSK2 has also been implicated in insulin secretion and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual disability Loss-of-function mutations in BRSK2 impair neuronal polarity and synaptic signaling ClinVar, OMIM
Autism spectrum disorder De novo missense variants disrupt kinase activity and neuronal development ClinVar, OMIM
Diabetes (type 2) BRSK2 regulates insulin granule exocytosis in pancreatic beta cells UniProt, NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 56.3 High
Testis 12.1 Medium
Pancreas 8.5 Medium
Kidney 4.2 Low
Liver 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 45.7 High expression
HeLa (cervical carcinoma) 12.3 Moderate expression
HEK293 (embryonic kidney) 8.9 Moderate expression
MCF7 (breast cancer) 3.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1042C>T (p.Arg348Trp) Missense Rare Loss of kinase activity; associated with intellectual disability
c.157G>A (p.Glu53Lys) Missense De novo Impaired autophosphorylation; linked to autism
c.1234delC (p.Leu412Trpfs*5) Frameshift Rare Truncated protein; loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the kinase domain or disrupt ATP binding lead to loss of catalytic activity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in BRSK2.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by interfering with dimerization or substrate binding, though evidence is limited.

Gene Ontology (GO)

• GO:0004674 (protein serine/threonine kinase activity) • GO:0005524 (ATP binding)
• GO:0006468 (protein phosphorylation) • GO:0007409 (axonogenesis)
• GO:0031175 (neuron projection development) • GO:0018105 (peptidyl-serine phosphorylation)
• GO:0046777 (protein autophosphorylation)

Pathways

AMPK signaling pathway (Reactome: R-HSA-380952)
LKB1 signaling events (Reactome: R-HSA-5628897)
Neuronal system (Reactome: R-HSA-112316)

Protein Summary

BRSK2 is a 741-amino acid serine/threonine kinase belonging to the AMPK-related kinase family. It contains an N-terminal kinase domain and a C-terminal regulatory domain. The protein is activated by LKB1-mediated phosphorylation at Thr174. BRSK2 localizes to the cytoplasm and is enriched in neuronal growth cones, where it phosphorylates microtubule-associated proteins such as Tau and MAP2 to regulate axon specification and elongation. It also modulates insulin secretion in pancreatic beta cells via phosphorylation of synapsin I.

Related Products

Product name Cat.No. Species Gene ID
BRSK2 Knockout HEK293 Cell Line EDJ-KQ2512 Human 9024 Details Get a Quote
BRSK2 Knockout A-549 Cell Line EDJ-KQ23118 Human 9024 Details Get a Quote
BRSK2 Knockout HCT 116 Cell Line EDJ-KQ21756 Human 9024 Details Get a Quote
BRSK2 Knockout HeLa Cell Line EDJ-KQ55057 Human 9024 Details Get a Quote
BRSK2 Knockout HAP1 Cell Line EDC07918 Human 9024 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: